Prelude Therapeutics Incorporated Share Price
PRLDPrelude Therapeutics Incorporated Stock Performance
Open $4.36 | Prev. Close $4.37 | Circuit Range N/A |
Day Range $4.36 - $4.99 | Year Range $0.76 - $5.54 | Volume 21,321 |
Average Traded $4.75 |
Prelude Therapeutics Incorporated Share Price Chart
About Prelude Therapeutics Incorporated
Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT3789, a selective degrader of SMARCA2 protein for the treatment of advanced or metastatic solid tumors with loss of SMARCA4 due to truncating mutation and/or deletion; PRT7732, a selective and orally bioavailable SMARCA2 degraders to treat advanced or metastatic solid tumors; and PRT2527, a cyclin-dependent kinase 9 inhibitor for the treatment of advanced solid tumors. The company's CDK9 program is a regulator of cancer-promoting transcriptional programs, including MCL1, MYC, and MYB. Prelude Therapeutics Incorporated was incorporated in 2016 and is based in Wilmington, Delaware.
Prelude Therapeutics Incorporated Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
29-Jun-26 | $4.36 | $4.90 | +0.00% |
29-Jun-26 | $4.36 | $4.90 | +12.00% |
26-Jun-26 | $4.21 | $4.38 | +6.86% |
25-Jun-26 | $4.38 | $4.09 | -4.23% |
24-Jun-26 | $4.47 | $4.28 | -2.29% |
23-Jun-26 | $4.36 | $4.38 | +1.63% |
22-Jun-26 | $4.45 | $4.30 | -0.12% |
FAQs on Prelude Therapeutics Incorporated Share Price
Can I buy Prelude Therapeutics Incorporated shares in India?
What is the share price of Prelude Therapeutics Incorporated?
What is the 5 year returns of Prelude Therapeutics Incorporated?
What are the high & low stock price of Prelude Therapeutics Incorporated today?
What is the 52-week high and low of Prelude Therapeutics Incorporated stock?